Publication | Closed Access

Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation

Hematological MalignancyTransplantationMarrow TransplantationMedicineHigh-dose MelphalanStem Cell TransplantationHematologyAmifostine CytoprotectionCell TransplantationOncologyRadiation OncologyMyeloma PatientsHealth Sciences